$2.28-0.15 (-6.17%)
Sunshine Biopharma, Inc.
Sunshine Biopharma, Inc. in the Healthcare sector is trading at $2.22. Wall Street consensus targets $56.00 (1 analysts), implying a +2424.8% move over the next 12 months. The stock is currently near its 52-week low of $2.06, remaining 82.2% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Sunshine Biopharma, Inc. operates as a pharmaceutical company that engages in the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. The company is develo...